Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer

Mario Muñoz, Pedro T. Ramirez, Carolina Echeverri, Luis Guillermo Álvarez, Maria Alejandra Palomino, Luis René Pareja

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

To report the clinical presentation and oncologic outcomes of a series of patients who presented with an abdominal or pelvic mass and were diagnosed with a gastrointestinal stromal tumor (GIST). Methods: Data were obtained on all patients who presented with an abdominal or pelvic mass between September 2007 and June 2010 and who were ultimately diagnosed with a GIST. The patients' medical records were reviewed. A literature review was also conducted. Results: Six patients were identified who met the inclusion criteria. All six patients had a tumor in the intestinal tract arising from the small bowel. The mean tumor size was 12 cm (range, 6 to 22 cm). A complete resection was achieved in five of the six patients. There were no intraoperative complications; one patient had a postoperative complication. Two patients were treated with imatinib after surgery. The mean follow-up time was 32 months (range, 0.3 to 40 months). At the last follow-up, five of the six patients were without any evidence of disease. One patient died of an unrelated hepatic encephalopathy. The incidence in our institution is 3%. Conclusion: GISTs are uncommon; however, they should be considered in the differential diagnosis of patients presenting with an abdominal or pelvic mass.

Original languageEnglish (US)
Pages (from-to)49-52
Number of pages4
JournalJournal of Gynecologic Oncology
Volume23
Issue number1
DOIs
StatePublished - 2012

Keywords

  • Adnexal mass
  • Gastrointestinal stromal tumor
  • Incidental finding

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer'. Together they form a unique fingerprint.

Cite this